In vitro platform mimicking human small intestine epithelium
An advanced in vitro model replicating human small intestine epithelium using a synthetic biomimetic scaffold, enabling precise study of transport and efflux mechanisms under physiological conditions.
Overview
The University of Würzburg has developed an innovative in vitro platform that accurately simulates the human small intestinal epithelium. This Transwell-like setup offers an apical-basolateral orientation crucial for studying transport functions and efflux mechanisms. By replicating physiological uptake mechanisms, the platform enhances the understanding of intestinal absorption and transport dynamics, contributing to ethical research aligned with the 3Rs principle.
Technical specifications
The platform utilizes a synthetic, fiber-based biomimetic scaffold seeded with intestinal fibroblasts from human tissue biopsies. This scaffold supports the growth of human intestinal organoids, forming a polarized monolayer that mirrors in vivo intestinal epithelium. Key features include:
- Biomimetic scaffold: Provides a biologically active matrix for cell growth.
- Polarized monolayer: Ensures accurate apical-basolateral orientation for studying intestinal dynamics.
- Reliable in vitro model: Facilitates robust assessments of transport and efflux functions.
Technology readiness level
This in vitro platform is at Technology Readiness Level 3, having undergone comprehensive characterization and validation studies, including histology, immunofluorescence, and TEER measurements. Future plans involve further refinement with a synthetic matrix to enhance its application in physiological research.
About University of Würzburg
Julius-Maximilians-Universität Würzburg is a large public research university with more than 25,000 students and about 5,100 employees, combining broad academic scope with a strong research and medical profile. Its close integration with University Hospital Würzburg links university, preclinical, and clinical institutes in research, teaching, and patient care, supporting clinically relevant collaboration. The university’s Service Centre Research and Technology Transfer supports company partnerships, inventions, patents, licensing, entrepreneurship, and startup formation. Research is supported by competitive funding from the German Research Foundation, Germany’s federal ministries, and European Union programmes. This combination of university-scale expertise, hospital access, and formal transfer support offers corporate R&D teams a practical route from scientific engagement toward application.
delivered to your inbox.